In fiscal year 2024, the U.S. Department of Justice (DOJ) announced that it recouped over $2.9 billion through settlements and judgments under the False Claims Act (FCA). This marks a 30% increase compared to the previous two years. Here are some key points: Healthcare Fraud: The majority of the recoveries, approximately $1.67 billion, were related…
Read MoreThe Department of Justice (DOJ) has recently updated its Evaluation of Corporate Compliance Programs (ECCP) to address the use of artificial intelligence (AI) in compliance programs. This update, released on September 23, 2024, emphasizes the importance of integrating AI responsibly and effectively into compliance frameworks. Key points from the update include: Risk Management: Companies must…
Read MoreThe Drug Enforcement Administration (DEA) has finalized a one-year extension of telehealth prescribing flexibilities for controlled substances, extending the policy through December 31, 2025. This extension allows healthcare providers to continue prescribing Schedule II-V controlled substances via telehealth without requiring an in-person visit. The decision was made in response to the ongoing need for accessible…
Read More